Apotex Paxil ANDA: Presence Of Hemihydrate Does Not Infringe GSK’s Patent

Apotex' generic version of Paxil would not infringe GSK's hemihydrate paroxetine patent because the generic does not contain a commercially significant amount of hemihydrate crystals, a Chicago district court decision says

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet